Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron N Winn

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
The Oncologist|February 8, 2019
Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in OncologyAaron P Mitchell, Aaron N Winn, Jennifer L Lund, et al.
American Journal of Preventive Medicine|October 17, 2015
Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic ReviewAaron N Winn, Donatus U Ekwueme, Gery P Guy, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2017
Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosisYi-Ting Chou, Aaron N Winn, Donald L Rosenstein, et al.
Annals of Internal Medicine|April 17, 2023
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor AgonistsNeda Laiteerapong, Jason Alexander, Louis Philipson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Cost-utility analyses in diabetes: a systematic review and implications from real-world evidenceYue Zhong, Pei-Jung Lin, Joshua T Cohen, et al.
JAMA Oncology|November 10, 2017
Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity LawsStacie B Dusetzina, Haiden A Huskamp, Aaron N Winn, et al.
Circulation. Cardiovascular Quality and Outcomes|October 21, 2016
Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?Emma Aarnio, Janne Martikainen, Aaron N Winn, et al.
Journal of General Internal Medicine|April 27, 2021
The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' PaymentsAaron N Winn, Aaron P Mitchell, Nicole Fergestrom, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2020
The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherenceAaron N Winn, Nicole M Fergestrom, Liliana E Pezzin, et al.
JAMA Oncology|February 23, 2018
Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014Aaron N Winn, Nancy L Keating, Justin G Trogdon, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
The Oncologist|February 8, 2019
Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in OncologyAaron P Mitchell, Aaron N Winn, Jennifer L Lund, et al.
American Journal of Preventive Medicine|October 17, 2015
Cost-Utility Analysis of Cancer Prevention, Treatment, and Control: A Systematic ReviewAaron N Winn, Donatus U Ekwueme, Gery P Guy, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2017
Assessing disruptions in adherence to antidepressant treatments after breast cancer diagnosisYi-Ting Chou, Aaron N Winn, Donald L Rosenstein, et al.
Annals of Internal Medicine|April 17, 2023
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor AgonistsNeda Laiteerapong, Jason Alexander, Louis Philipson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 17, 2015
Cost-utility analyses in diabetes: a systematic review and implications from real-world evidenceYue Zhong, Pei-Jung Lin, Joshua T Cohen, et al.
JAMA Oncology|November 10, 2017
Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity LawsStacie B Dusetzina, Haiden A Huskamp, Aaron N Winn, et al.
Circulation. Cardiovascular Quality and Outcomes|October 21, 2016
Socioeconomic Inequalities in Statin Adherence Under Universal Coverage: Does Sex Matter?Emma Aarnio, Janne Martikainen, Aaron N Winn, et al.
Journal of General Internal Medicine|April 27, 2021
The Role of Physician Professional Networks in Physicians' Receipt of Pharmaceutical and Medical Device Industries' PaymentsAaron N Winn, Aaron P Mitchell, Nicole Fergestrom, et al.
Pharmacoepidemiology and Drug Safety|March 21, 2020
The impact of generic aromatase inhibitors on initiation, adherence, and persistence among women with breast cancer: Applying multi-state models to understand the dynamics of adherenceAaron N Winn, Nicole M Fergestrom, Liliana E Pezzin, et al.
JAMA Oncology|February 23, 2018
Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014Aaron N Winn, Nancy L Keating, Justin G Trogdon, et al.
Pageof 8